Clinical Trial

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

Study acronym: tDCS
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus
Protocol Amendment History 4 changes
critical Trial status changed: Unknown → Recruiting 2026-08-05
notable Primary completion pushed: 2024-12-31 -> 2026-10-01 2026-08-05
minor Completion pushed: 2025-03-31 -> 2026-10-01 2026-08-05
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06344338
Lead Sponsor Xuanwu Hospital, Beijing
Conditions Refractory Status Epilepticus
Enrollment 32 participants
Start Date 2024-04-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-04